ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.704,42
-0,11%
S&P 500
5.303,27
0,12%
Dow Jones
40.003,59
0,34%
Euro vs US Dollar
1,08731
-0,20%
Bitcoin
66.276,31
-0,99%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Talis Biomedical Corporation (TLIS)

  7. Talis Biomedical Corporation (TLIS) News

TLIS

Talis Biomedical (TLIS)

Talis Biomedical Corporation
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:TLIS
DatumZeitQuelleÜberschriftSymbolFirma
08/05/202414h04Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TLISTalis Biomedical Corporation
26/01/202422h33Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TLISTalis Biomedical Corporation
14/11/202314h00GlobeNewswire Inc.Talis Biomedical Announces Exploration of Strategic Alternatives and Cost Reduction Plan to Preserve CashNASDAQ:TLISTalis Biomedical Corporation
01/09/202323h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TLISTalis Biomedical Corporation
10/08/202323h01Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:TLISTalis Biomedical Corporation
10/08/202322h46Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TLISTalis Biomedical Corporation
10/08/202322h11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TLISTalis Biomedical Corporation
10/08/202322h05GlobeNewswire Inc.Talis Biomedical Announces Second Quarter 2023 Financial Results and Business UpdateNASDAQ:TLISTalis Biomedical Corporation
03/08/202314h00GlobeNewswire Inc.Talis Biomedical to Report Second Quarter 2023 Financial Results and Provide a Business Update on August 10, 2023NASDAQ:TLISTalis Biomedical Corporation
02/08/202314h18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TLISTalis Biomedical Corporation
02/08/202314h17Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TLISTalis Biomedical Corporation
02/08/202314h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TLISTalis Biomedical Corporation
02/08/202314h00GlobeNewswire Inc.Talis Biomedical Announces Andrew Lukowiak, Ph.D., as President and Chief Scientific Officer (CSO)NASDAQ:TLISTalis Biomedical Corporation
27/07/202314h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TLISTalis Biomedical Corporation
27/07/202314h00GlobeNewswire Inc.New Data Presented at the Infectious Disease Society for Obstetrics and Gynecology (IDSOG) Annual Meeting Differentiate Talis Biomedical’s Women’s and Sexual Health Product MenuNASDAQ:TLISTalis Biomedical Corporation
24/07/202314h41Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TLISTalis Biomedical Corporation
24/07/202314h00GlobeNewswire Inc.Talis Biomedical Regains Compliance with Nasdaq Minimum Bid Price RequirementNASDAQ:TLISTalis Biomedical Corporation
18/07/202323h37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TLISTalis Biomedical Corporation
05/07/202314h10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TLISTalis Biomedical Corporation
05/07/202314h00GlobeNewswire Inc.Talis Biomedical Announces 1-for-15 Reverse Stock SplitNASDAQ:TLISTalis Biomedical Corporation
13/06/202322h53Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TLISTalis Biomedical Corporation
12/06/202323h28Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TLISTalis Biomedical Corporation
12/06/202323h26Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TLISTalis Biomedical Corporation
12/06/202323h24Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TLISTalis Biomedical Corporation
12/06/202323h22Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TLISTalis Biomedical Corporation
12/06/202323h14Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TLISTalis Biomedical Corporation
09/06/202322h11Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TLISTalis Biomedical Corporation
23/05/202314h16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TLISTalis Biomedical Corporation
23/05/202314h00GlobeNewswire Inc.Talis Biomedical Appoints Former Roche Molecular CEO Heiner Dreismann to Board of Directors, Announces Former Genomic Health CEO Kim Popovits as Lead Independent DirectorNASDAQ:TLISTalis Biomedical Corporation
11/05/202322h38Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TLISTalis Biomedical Corporation
 Showing the most relevant articles for your search:NASDAQ:TLIS

Kürzlich von Ihnen besucht

ASX
SRF
SurfStitch
LSE
AQ50
City Gotebg 28
COIN
BIHEUR
COIN
CRMEUR
EU
UNECM
UNEDIC 0.25% until 07/35
LSE
0QV2
Bactiguard Holding Ab
TSXV
TRL.H
Trilogy International Pa...
NASDAQ
GLEE
Gladstone Acquisition
COIN
BLTVEUR
BIT
ACWIA
Exchange Traded Fund Ubs...
NASDAQ
ACBI
Atlantic Capital Bancsha...
AMEX
AFCO
AMERICAN FARMLAND CO
COIN
NBXGBTC
BIT
P1AJ19
BNP Paribas Issuance
AMEX
PEL
NYSE
MHNB.CL
Maiden Holdings North America
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten